Global Drugs for Short Bowel Syndrome Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 111
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drugs for Short Bowel Syndrome companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Drugs for Short Bowel Syndrome market. Further, it explains the major drivers and regional dynamics of the global Drugs for Short Bowel Syndrome market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Ardelyx

- Emmaus Life Sciences

- GLyPharma Therapeutic

- Merck

- Naia Pharmaceuticals

- Nutrinia

- OxThera

- Sancilio & Company

- Takeda

- Zealand Pharma

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Drugs for Short Bowel Syndrome Segment by Type

- GLP-2

- Growth Hormone

- Glutamine

- Other

Drugs for Short Bowel Syndrome Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Drugs for Short Bowel Syndrome market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Drugs for Short Bowel Syndrome market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Drugs for Short Bowel Syndrome, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drugs for Short Bowel Syndrome, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drugs for Short Bowel Syndrome revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Drugs for Short Bowel Syndrome market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Drugs for Short Bowel Syndrome revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Ardelyx, Emmaus Life Sciences, GLyPharma Therapeutic, Merck, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio & Company and Takeda, etc.

Global Drugs for Short Bowel Syndrome Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 GLP-2
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Drugs for Short Bowel Syndrome Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Drugs for Short Bowel Syndrome Market Size (2017-2028)
2.2 Drugs for Short Bowel Syndrome Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Drugs for Short Bowel Syndrome Market Size by Region (2017-2022)
2.4 Global Drugs for Short Bowel Syndrome Market Size Forecast by Region (2023-2028)
2.5 Global Top Drugs for Short Bowel Syndrome Countries Ranking by Market Size
3 Drugs for Short Bowel Syndrome Competitive by Company
3.1 Global Drugs for Short Bowel Syndrome Revenue by Players
3.1.1 Global Drugs for Short Bowel Syndrome Revenue by Players (2017-2022)
3.1.2 Global Drugs for Short Bowel Syndrome Market Share by Players (2017-2022)
3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2021
3.5 Global Drugs for Short Bowel Syndrome Key Players Head office and Area Served
3.6 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
3.7 Date of Enter into Drugs for Short Bowel Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Drugs for Short Bowel Syndrome Breakdown Data by Type
4.1 Global Drugs for Short Bowel Syndrome Historic Revenue by Type (2017-2022)
4.2 Global Drugs for Short Bowel Syndrome Forecasted Revenue by Type (2023-2028)
5 Global Drugs for Short Bowel Syndrome Breakdown Data by Application
5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Short Bowel Syndrome Revenue by Company (2020-2022)
6.2 North America Drugs for Short Bowel Syndrome Revenue by Type (2017-2028)
6.3 North America Drugs for Short Bowel Syndrome Revenue by Application (2017-2028)
6.4 North America Drugs for Short Bowel Syndrome Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Drugs for Short Bowel Syndrome Revenue by Company (2020-2022)
7.2 Europe Drugs for Short Bowel Syndrome Revenue by Type (2017-2028)
7.3 Europe Drugs for Short Bowel Syndrome Revenue by Application (2017-2028)
7.4 Europe Drugs for Short Bowel Syndrome Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Drugs for Short Bowel Syndrome Revenue by Company (2020-2022)
8.2 Asia Pacific Drugs for Short Bowel Syndrome Revenue by Type (2017-2028)
8.3 Asia Pacific Drugs for Short Bowel Syndrome Revenue by Application (2017-2028)
8.4 Asia Pacific Drugs for Short Bowel Syndrome Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Drugs for Short Bowel Syndrome Revenue by Company (2020-2022)
9.2 Latin America Drugs for Short Bowel Syndrome Revenue by Type (2017-2028)
9.3 Latin America Drugs for Short Bowel Syndrome Revenue by Application (2017-2028)
9.4 Latin America Drugs for Short Bowel Syndrome Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Company (2020-2022)
10.2 Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Type (2017-2028)
10.3 Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Application (2017-2028)
10.4 Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Ardelyx
11.1.1 Ardelyx Company Details
11.1.2 Ardelyx Business Overview
11.1.3 Ardelyx Drugs for Short Bowel Syndrome Products and Services
11.1.4 Ardelyx Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.1.5 Ardelyx Drugs for Short Bowel Syndrome SWOT Analysis
11.1.6 Ardelyx Recent Developments
11.2 Emmaus Life Sciences
11.2.1 Emmaus Life Sciences Company Details
11.2.2 Emmaus Life Sciences Business Overview
11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Products and Services
11.2.4 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.2.5 Emmaus Life Sciences Drugs for Short Bowel Syndrome SWOT Analysis
11.2.6 Emmaus Life Sciences Recent Developments
11.3 GLyPharma Therapeutic
11.3.1 GLyPharma Therapeutic Company Details
11.3.2 GLyPharma Therapeutic Business Overview
11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Products and Services
11.3.4 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.3.5 GLyPharma Therapeutic Drugs for Short Bowel Syndrome SWOT Analysis
11.3.6 GLyPharma Therapeutic Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Drugs for Short Bowel Syndrome Products and Services
11.4.4 Merck Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.4.5 Merck Drugs for Short Bowel Syndrome SWOT Analysis
11.4.6 Merck Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Details
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Products and Services
11.5.4 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.5.5 Naia Pharmaceuticals Drugs for Short Bowel Syndrome SWOT Analysis
11.5.6 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Company Details
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Drugs for Short Bowel Syndrome Products and Services
11.6.4 Nutrinia Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.6.5 Nutrinia Drugs for Short Bowel Syndrome SWOT Analysis
11.6.6 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Company Details
11.7.2 OxThera Business Overview
11.7.3 OxThera Drugs for Short Bowel Syndrome Products and Services
11.7.4 OxThera Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.7.5 OxThera Drugs for Short Bowel Syndrome SWOT Analysis
11.7.6 OxThera Recent Developments
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Details
11.8.2 Sancilio & Company Business Overview
11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Products and Services
11.8.4 Sancilio & Company Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.8.5 Sancilio & Company Drugs for Short Bowel Syndrome SWOT Analysis
11.8.6 Sancilio & Company Recent Developments
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Drugs for Short Bowel Syndrome Products and Services
11.9.4 Takeda Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.9.5 Takeda Drugs for Short Bowel Syndrome SWOT Analysis
11.9.6 Takeda Recent Developments
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Details
11.10.2 Zealand Pharma Business Overview
11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Products and Services
11.10.4 Zealand Pharma Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.10.5 Zealand Pharma Drugs for Short Bowel Syndrome SWOT Analysis
11.10.6 Zealand Pharma Recent Developments
12 Drugs for Short Bowel Syndrome Market Dynamics
12.1 Drugs for Short Bowel Syndrome Market Trends
12.2 Drugs for Short Bowel Syndrome Market Drivers
12.3 Drugs for Short Bowel Syndrome Market Challenges
12.4 Drugs for Short Bowel Syndrome Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of GLP-2
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Glutamine
Table 5. Key Players of Other
Table 6. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Drugs for Short Bowel Syndrome Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Drugs for Short Bowel Syndrome Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Drugs for Short Bowel Syndrome Revenue Market Share by Region (2017-2022)
Table 10. Global Drugs for Short Bowel Syndrome Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Drugs for Short Bowel Syndrome Market Share by Players (2017-2022)
Table 12. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2021)
Table 13. Ranking of Global Top Drugs for Short Bowel Syndrome Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Drugs for Short Bowel Syndrome Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Drugs for Short Bowel Syndrome Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Drugs for Short Bowel Syndrome Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Drugs for Short Bowel Syndrome Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2017-2022)
Table 21. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2023-2028)
Table 23. Global Drugs for Short Bowel Syndrome Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2017-2022)
Table 25. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Drugs for Short Bowel Syndrome Revenue Market Share by Application (2023-2028)
Table 27. North America Drugs for Short Bowel Syndrome Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Drugs for Short Bowel Syndrome Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Drugs for Short Bowel Syndrome Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Drugs for Short Bowel Syndrome Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Drugs for Short Bowel Syndrome Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Drugs for Short Bowel Syndrome Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Drugs for Short Bowel Syndrome Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Drugs for Short Bowel Syndrome Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Drugs for Short Bowel Syndrome Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Drugs for Short Bowel Syndrome Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Drugs for Short Bowel Syndrome Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Drugs for Short Bowel Syndrome Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Drugs for Short Bowel Syndrome Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Drugs for Short Bowel Syndrome Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Drugs for Short Bowel Syndrome Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Drugs for Short Bowel Syndrome Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Drugs for Short Bowel Syndrome Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Drugs for Short Bowel Syndrome Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Drugs for Short Bowel Syndrome Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Drugs for Short Bowel Syndrome Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Drugs for Short Bowel Syndrome Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Drugs for Short Bowel Syndrome Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Drugs for Short Bowel Syndrome Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Drugs for Short Bowel Syndrome Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Drugs for Short Bowel Syndrome Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Drugs for Short Bowel Syndrome Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Drugs for Short Bowel Syndrome Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Drugs for Short Bowel Syndrome Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Drugs for Short Bowel Syndrome Revenue by Country (2023-2028) & (US$ Million)
Table 62. Ardelyx Company Details
Table 63. Ardelyx Business Overview
Table 64. Ardelyx Drugs for Short Bowel Syndrome Product and Services
Table 65. Ardelyx Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 66. Ardelyx Drugs for Short Bowel Syndrome SWOT Analysis
Table 67. Ardelyx Recent Developments
Table 68. Emmaus Life Sciences Company Details
Table 69. Emmaus Life Sciences Business Overview
Table 70. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product and Services
Table 71. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 72. Emmaus Life Sciences Drugs for Short Bowel Syndrome SWOT Analysis
Table 73. Emmaus Life Sciences Recent Developments
Table 74. GLyPharma Therapeutic Company Details
Table 75. GLyPharma Therapeutic Business Overview
Table 76. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product and Services
Table 77. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 78. GLyPharma Therapeutic Drugs for Short Bowel Syndrome SWOT Analysis
Table 79. GLyPharma Therapeutic Recent Developments
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Drugs for Short Bowel Syndrome Product and Services
Table 83. Merck Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 84. Merck Drugs for Short Bowel Syndrome SWOT Analysis
Table 85. Merck Recent Developments
Table 86. Naia Pharmaceuticals Company Details
Table 87. Naia Pharmaceuticals Business Overview
Table 88. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product and Services
Table 89. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 90. Naia Pharmaceuticals Drugs for Short Bowel Syndrome SWOT Analysis
Table 91. Naia Pharmaceuticals Recent Developments
Table 92. Nutrinia Company Details
Table 93. Nutrinia Business Overview
Table 94. Nutrinia Drugs for Short Bowel Syndrome Product and Services
Table 95. Nutrinia Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 96. Nutrinia Drugs for Short Bowel Syndrome SWOT Analysis
Table 97. Nutrinia Recent Developments
Table 98. OxThera Company Details
Table 99. OxThera Business Overview
Table 100. OxThera Drugs for Short Bowel Syndrome Product and Services
Table 101. OxThera Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 102. OxThera Drugs for Short Bowel Syndrome SWOT Analysis
Table 103. OxThera Recent Developments
Table 104. Sancilio & Company Company Details
Table 105. Sancilio & Company Business Overview
Table 106. Sancilio & Company Drugs for Short Bowel Syndrome Product and Services
Table 107. Sancilio & Company Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 108. Sancilio & Company Drugs for Short Bowel Syndrome SWOT Analysis
Table 109. Sancilio & Company Recent Developments
Table 110. Takeda Company Details
Table 111. Takeda Business Overview
Table 112. Takeda Drugs for Short Bowel Syndrome Product and Services
Table 113. Takeda Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 114. Takeda Drugs for Short Bowel Syndrome SWOT Analysis
Table 115. Takeda Recent Developments
Table 116. Zealand Pharma Company Details
Table 117. Zealand Pharma Business Overview
Table 118. Zealand Pharma Drugs for Short Bowel Syndrome Product and Services
Table 119. Zealand Pharma Drugs for Short Bowel Syndrome Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 120. Zealand Pharma Drugs for Short Bowel Syndrome SWOT Analysis
Table 121. Zealand Pharma Recent Developments
Table 122. Drugs for Short Bowel Syndrome Market Trends
Table 123. Drugs for Short Bowel Syndrome Market Drivers
Table 124. Drugs for Short Bowel Syndrome Market Challenges
Table 125. Drugs for Short Bowel Syndrome Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Short Bowel Syndrome Sales Market Share by Type: 2021 VS 2028
Figure 2. GLP-2 Features
Figure 3. Growth Hormone Features
Figure 4. Glutamine Features
Figure 5. Other Features
Figure 6. Global Drugs for Short Bowel Syndrome Sales Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drugs for Short Bowel Syndrome Report Years Considered
Figure 11. Global Drugs for Short Bowel Syndrome Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Drugs for Short Bowel Syndrome Market Size 2017-2028 (US$ Million)
Figure 13. Global Drugs for Short Bowel Syndrome Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Drugs for Short Bowel Syndrome Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Drugs for Short Bowel Syndrome Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Drugs for Short Bowel Syndrome Market Share by Players in 2021
Figure 17. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2021
Figure 19. North America Drugs for Short Bowel Syndrome Revenue Market Share by Company in 2021
Figure 20. North America Drugs for Short Bowel Syndrome Revenue Market Share by Type (2017-2028)
Figure 21. North America Drugs for Short Bowel Syndrome Revenue Market Share by Application (2017-2028)
Figure 22. North America Drugs for Short Bowel Syndrome Revenue Share by Country (2017-2028)
Figure 23. U.S. Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Drugs for Short Bowel Syndrome Revenue Market Share by Company in 2021
Figure 26. Europe Drugs for Short Bowel Syndrome Revenue Market Share by Type (2017-2028)
Figure 27. Europe Drugs for Short Bowel Syndrome Revenue Market Share by Application (2017-2028)
Figure 28. Europe Drugs for Short Bowel Syndrome Revenue Share by Country (2017-2028)
Figure 29. Germany Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 30. France Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Drugs for Short Bowel Syndrome Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Drugs for Short Bowel Syndrome Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Drugs for Short Bowel Syndrome Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Drugs for Short Bowel Syndrome Revenue Share by Region (2017-2028)
Figure 38. China Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 41. India Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 43. China Taiwan Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 47. Latin America Drugs for Short Bowel Syndrome Revenue Market Share by Company in 2021
Figure 48. Latin America Drugs for Short Bowel Syndrome Revenue Market Share by Type (2017-2028)
Figure 49. Latin America Drugs for Short Bowel Syndrome Revenue Market Share by Application (2017-2028)
Figure 50. Latin America Drugs for Short Bowel Syndrome Revenue Share by Country (2017-2028)
Figure 51. Mexico Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 52. Brazil Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 53. Argentina Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Market Share by Company in 2021
Figure 55. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Market Share by Type (2017-2028)
Figure 56. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Market Share by Application (2017-2028)
Figure 57. Middle East and Africa Drugs for Short Bowel Syndrome Revenue Share by Country (2017-2028)
Figure 58. Turkey Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 59. Saudi Arabia Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 60. UAE Drugs for Short Bowel Syndrome Revenue (2017-2028) & (US$ Million)
Figure 61. Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 62. Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 63. GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 65. Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 66. Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 67. OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 68. Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 69. Takeda Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 70. Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
  • Global Orthopedic Navigation Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 116
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Orthopedic Navigation Systems manufacturers, distributors, end users, industry associations, governments' industry bureaus,......
  • Global Needle-Free Drug Delivery Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 113
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Needle-Free Drug Delivery Systems manufacturers, distributors, end users, industry associations, governments' industry bure......
  • Global Multi-Function Infrared Thermometer Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 112
    Report Scope This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Multi-Function Infrared Thermometer manufacturers, distributors, end users, industry as......
  • Global Healthcare Clinical Trial Management Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 111
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Healthcare Clinical Trial Management Systems manufacturers, distributors, end users, industry associations, governments' in......
  • Global ENT Navigation Systems Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 114
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the ENT Navigation Systems manufacturers, distributors, end users, industry associations, governments' industry bureaus, indust......
  • Global Electronic Pressure Regulators Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 113
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Electronic Pressure Regulators manufacturers, distributors, end users, industry associations, governments' industry bureaus......
  • Global Digital Dental Impression Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 116
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Digital Dental Impression Devices manufacturers, distributors, end users, industry associations, governments' industry bure......
  • Global Atherectomy Devices Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 107
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Atherectomy Devices manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry ......
  • Global Bronchoscope Video Endoscopes Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 22-Sep-2022        Price: US 5600 Onwards        Pages: 118
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bronchoscope Video Endoscopes manufacturers, distributors, end users, industry associations, governments' industry bureaus,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs